Homebiotech

biotech

biotech

Topline results from metastatic breast cancer phase 3 trial

Jim Cornall - October 28, 2026

biotech

Updated prostate cancer results show anti-tumour activity

Jim Cornall - October 28, 2026

biotech

Gesynta Pharma continues endometriosis work

Jim Cornall - October 28, 2026

biotech

First-in-human circular RNA therapy for radiation-induced xerostomia

Jim Cornall - October 27, 2026

biotech

New CRISPR method makes it possible to control protein production in cells

Jim Cornall - July 9, 2026

biotech

KAIST enables DNA synthesis using only temperature

Jim Cornall - July 9, 2026

biotech

Novartis to acquire Myricx Bio

Jim Cornall - July 9, 2026

biotech

New approach to rare disease drug development yields first research results

Jim Cornall - July 8, 2026

biotech

PFAS in medicines can often be replaced with alternatives

Jim Cornall - July 8, 2026

biotech

Polyomaviruses: new approaches to prevention and treatment

Jim Cornall - July 7, 2026

biotech

ten23 health obtains Swissmedic licences for Basel and Visp facilities

Jim Cornall - July 7, 2026

biotech

SK bioscience launches initiative to reduce uncertainty in vaccine-development decisions

Jim Cornall - July 7, 2026

1...202122...108 Page 21 of 108

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Topline results from metastatic breast cancer phase 3 trial

Jim Cornall - October 28, 2026 0

BioNTech SE and DualityBiologics (Suzhou) Co., Ltd. have announced that the DYNASTY-Breast02 global phase 3 clinical trial met its primary endpoint. This demonstrated a statistically...

Updated prostate cancer results show anti-tumour activity

biotech Jim Cornall - October 28, 2026 0

Gesynta Pharma continues endometriosis work

biotech Jim Cornall - October 28, 2026 0

First-in-human circular RNA therapy for radiation-induced xerostomia

biotech Jim Cornall - October 27, 2026 0

Data show unresectable patients becoming eligible for surgery

biotech Jim Cornall - October 27, 2026 0